Google
Apple
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
GI INNOVATION, INC. |
End-of-day quote
Other stock markets
|
|
5-day change | 1st Jan Change | |
| 20,100.00 KRW | +1.01% | +4.04% | 0.00% | |
| Sep. 18 | GI Innovation, Inc.(KOSDAQ:A358570) added to S&P Global BMI Index | CI |
| Mar. 24 | GI Innovation, Inc. has completed an IPO in the amount of KRW 26 billion. | CI |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions on site
| Sales 2023 * | 13 0 | Sales 2024 * | 198 0 | Capitalization | 444 B 344 M |
|---|---|---|---|---|---|
| Net income 2023 * | -72 0 | Net income 2024 * | 107 0 | EV / Sales 2023 * | 34,1x |
| Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 2,24x |
| P/E ratio 2023 * | -6,10x | P/E ratio 2024 * | 4,13x | Employees | - |
| Yield 2023 * | - | Yield 2024 * | - | Free-Float | 88.80% |
More Fundamentals
* Assessed data
| 1 day | +1.01% | ||
| 1 week | +4.04% | ||
| Current month | +15.45% | ||
| 1 month | +19.64% | ||
| 3 months | -15.37% | ||
| 6 months | -12.80% |
1 week
18 910.00
20 500.00
1 month
16 230.0020 500.00
Current year
16 160.0031 400.00
1 year
16 160.0031 400.00
3 years
16 160.0031 400.00
5 years
16 160.0031 400.00
10 years
16 160.0031 400.00
| Managers | Title | Age | Since |
|---|---|---|---|
Jun-Ho Hong
CEO | Chief Executive Officer | 51 | - |
Byeong-Geon Lee
CEO | Chief Executive Officer | 67 | 2022 |
Su-Yeon Nam
PSD | President | 57 | 2018 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Byeong-Geon Lee
CEO | Chief Executive Officer | 67 | 2022 |
Su-Yeon Nam
PSD | President | 57 | 2018 |
Jun-Ho Hong
CEO | Chief Executive Officer | 51 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23-11-28 | 20,100.00 | +1.01% | 99,344 |
| 23-11-27 | 19,900.00 | -1.73% | 127,206 |
| 23-11-24 | 20,250.00 | +0.75% | 136,695 |
| 23-11-23 | 20,100.00 | +6.57% | 318,622 |
| 23-11-22 | 18,860.00 | -2.38% | 83,489 |
End-of-day quote Korea Stock Exchange, November 27, 2023
More quotes
GI Innovation Inc is a Korea-based company engaged in the research and development of next-generation immunotherapies based on fusion proteins. The Company is engaged in the business of generating revenue through license fees by technology transfer of new drug candidates in pre-clinical and early clinical stages. The core new drug pipeline includes products such as GI-101 immuno-oncology and GI-301 allergy treatment.
Calendar
2024-03-20
- Q4 2023 Earnings Release (Projected)
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
20,100.00KRW
Average target price
43,000.00KRW
Spread / Average Target
+113.93%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. (M$) | |
|---|---|---|
| 0.00% | 344 M $ | |
| +66.65% | 40 404 M $ | |
| +2.98% | 38 508 M $ | |
| -56.47% | 29 809 M $ | |
| -24.87% | 28 695 M $ | |
| +37.75% | 22 029 M $ | |
| -32.10% | 20 250 M $ | |
| +2.80% | 17 781 M $ | |
| -17.15% | 10 827 M $ | |
| -10.41% | 10 014 M $ |
